American Society of Hematology

SHERPA: Blue

People

  1. Noy
    Noy
  2. Zelenetz
    Zelenetz
  3. Horwitz
    Horwitz
  4. Hamlin
    Hamlin
  5. Palomba
    Palomba
  6. Moskowitz
    Moskowitz
  7. Kumar
    Kumar
  8. Caron
    Caron
  9. Yahalom
    Yahalom
  10. Owens
    Owens

Groups

  1. Center for Hematologic Malignancies (179)
  2. Department of Medicine (179)
  3. Hematologic Malignancies, Division of (179)
  4. Lymphoma (179)
  5. Population Sciences Research Program (87)
  6. Survivorship Research (86)
  7. Hematology-Oncology Fellows (73)
  8. Sloan Kettering Institute Postdocs (50)
  9. Epidemiology and Biostatistics (49)
  10. Weinberg Fellows (49)
Search Within
  1. "Ariela Noy"
Formats
  1. Meeting Abstract (140)
  2. Journal Article (36)
  3. Review (2)
  4. Research Letter (1)
Groups
  1. Center for Hematologic Malignancies (179)
  2. Department of Medicine (179)
  3. Hematologic Malignancies, Division of (179)
  4. Lymphoma (179)
  5. Population Sciences Research Program (87)
  6. Survivorship Research (86)

More Groups

People
  1. Ariela Noy (179)
  2. Andrew Zelenetz (109)
  3. Steven Horwitz (84)
  4. Paul Hamlin (83)
  5. David Straus (79)
  6. Maria Palomba (78)

More People

Years
  1. 2025 (2)
  2. 2024 (19)
  3. 2023 (14)
  4. 2022 (7)
  5. 2021 (13)
  6. 2020 (8)

More Years

Publications
  1. Blood (166)
  2. Blood Advances (13)

Results (179)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes among adult recipients of CAR T-cell therapy for Burkitt lymphoma
    Journal Article

    Samples, L.; Sadrzadeh, H.; Frigault, M. J.; Jacobson, C. A.; Hamadani, M.; Gurumurthi, A.; Strati, P.; Shouval, R.; Noy, A.; Riedell, P. A.; more...
    Blood (2025)

    Fulltext@MSK | Save
  • Characterizing the heterogeneity of Castleman disease and oligocentric subtype: Findings from the ACCELERATE registry
    Journal Article

    Pierson, S. K.; Brandstadter, J. D.; Torigian, D. A.; Bagg, A.; Lechowicz, M. J.; Alapat, D.; Casper, C.; Chadburn, A.; Chandrakasan, S.; Dispenzieri, A.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Rituximab plus /- ibrutinib as first line therapy for marginal zone lymphoma
    Meeting Abstract

    Noy, A.; Thet, W. S.; Vemuri, S.; Seshan, V.; Batlevi, C. L.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; Habermann, T. M.; Hamlin, P. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Two decade single institution experience highlights rare survivors with relapsed or refractory Burkitt lymphoma
    Meeting Abstract

    Molla, R.; Berman, E.; Caron, P.; Donnelly, G.; Falchi, L.; Hamlin, P. A.; Horwitz, S.; Intlekofer, A. M.; Johnson, W. T.; Jurcic, J. G.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Sequential R-CHOP/(R)-ICE and dose-adjusted EPOCH-R are both appropriate frontline treatments for newly diagnosed primary mediastinal B-cell lymphoma: Results of a retrospective analysis
    Meeting Abstract

    Bantilan, K. S.; Luttwak, E.; Moskowitz, C. H.; Matasar, M.; Straus, D. J.; Portlock, C. S.; Moskowitz, A.; Noy, A.; Palomba, M. L.; Horwitz, S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • A prospective geriatric assessment (GA) study predicting toxicities in older adults (OA) with non-Hodgkin Lymphoma (NHL): Timed up and go test (TUG) time emerges as a functional vital sign
    Meeting Abstract

    Torka, P.; Drill, E.; Ganesan, N.; Truong, R.; Qiu, A.; Amador, W. R.; Oliveros, M.; Boardman, A. P.; Caron, P.; David, K. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Pembrolizumab and involved site radiation therapy alone as an alternative to transplant in patients with localized failure following chemotherapy for Hodgkin Lymphoma: A prospective multicenter phase II study
    Meeting Abstract

    Dreyfuss, A.; Ganesan, N.; Alencar, A. J.; Boardman, A. P.; Caron, P.; Chang, T.; Davey, T.; David, K. A.; Dogan, A.; Epstein-Peterson, Z. D.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Improved outcomes for primary refractory classical Hodgkin Lymphoma: A retrospective analysis
    Meeting Abstract

    Santarosa, A. M.; Ganesan, N.; Chang, T.; Hannigan, K.; Casper, E.; Shah, G. L.; Boardman, A. P.; Caron, P.; David, K. A.; Dogan, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Real-world outcomes of frontline polatuzumab and impact of frailty in older adults with newly diagnosed diffuse large B-cell lymphoma (DLBCL)
    Meeting Abstract

    Iyengar, V.; Chicola, J.; Joseph, A.; Okwali, M.; Truong, R.; Bapodra, N.; Boardman, A. P.; Caron, P.; David, K. A.; Epstein-Peterson, Z. D.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Devimistat results in a low complete remission rate in heavily pre-treated Burkitt lymphoma
    Meeting Abstract

    Steiner, R.; Nikolaenko, L.; Kambhampati, S.; Khan, N.; Nair, R.; Abramson, J. S.; Horwitz, S.; Matasar, M.; Owens, C.; Rodriguez Rivera, I. I.; more...
    Blood (2024)

    Fulltext@MSK | Save